Macrolactins from Marine-Derived Bacillus subtilis B5 Bacteria as Inhibitors of Inducible Nitric Oxide and Cytokines Expression

Mar Drugs. 2016 Oct 26;14(11):195. doi: 10.3390/md14110195.

Abstract

In order to find new natural products with anti-inflammatory activity, chemical investigation of a 3000-meter deep-sea sediment derived bacteria Bacillus subtilis B5 was carried out. A new macrolactin derivative was isolated and identified as 7,13-epoxyl-macrolactin A (1). Owing to the existence of the epoxy ring, 1 exhibited a significant inhibitory effect on the expression of inducible nitric oxide and cytokines, compared with previously isolated known macrolactins (2-5). Real-time Polymerase Chain Reaction (PCR) analysis showed that the new compound significantly inhibited the mRNA expressions of inducible nitric oxide synthase (iNOS), interleukin-1β (IL-1β), and interleukin-6 (IL-6) in lipopolysaccharide (LPS)-stimulated RAW 264.7 macrophages. Reverse transcription-PCR analysis demonstrated that the new compound reduced the mRNA expression level of IL-1β in a concentration-dependent manner.

Keywords: 7,13-epoxyl-macrolactin A; Bacillus subtilis B5; anti-inflammatory; macrolactins.

MeSH terms

  • Animals
  • Anti-Inflammatory Agents / metabolism
  • Anti-Inflammatory Agents / pharmacology
  • Bacillus subtilis / metabolism*
  • Biological Products / pharmacology*
  • Cell Line
  • Cytokines / antagonists & inhibitors*
  • Cytokines / metabolism
  • Ethers, Cyclic / pharmacology*
  • Interleukin-1beta / metabolism
  • Interleukin-6 / metabolism
  • Macrophages / drug effects
  • Macrophages / metabolism
  • Mice
  • Nitric Oxide Synthase Type II / antagonists & inhibitors*
  • Nitric Oxide Synthase Type II / metabolism
  • RNA, Messenger / metabolism

Substances

  • Anti-Inflammatory Agents
  • Biological Products
  • Cytokines
  • Ethers, Cyclic
  • Interleukin-1beta
  • Interleukin-6
  • RNA, Messenger
  • Nitric Oxide Synthase Type II